MedPath

011010 NIACINAMIDE 4% / TRETINOIN 0.025%

011010 NIACINAMIDE 4% / TRETINOIN 0.025%

Approved
Approval ID

a97bf65b-35f2-ebea-e053-2a95a90aa482

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 2, 2020

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

011010 NIACINAMIDE 4% / TRETINOIN 0.025%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72934-1200
Product Classification
G
Generic Name
011010 NIACINAMIDE 4% / TRETINOIN 0.025%
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 2, 2020
FDA Product Classification

INGREDIENTS (2)

TRETINOINActive
Quantity: 0.025 g in 100 g
Code: 5688UTC01R
Classification: ACTIB
NIACINAMIDEActive
Quantity: 4 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

011010 NIACINAMIDE 4% / TRETINOIN 0.025% - FDA Drug Approval Details